Company / PP&E (Net)
ATOSSA THERAPEUTICS, INC. PP&E (Net) History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$171.6K
FY2016
5-year range
$160.0K / $357.5K
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $357,532 to $171,568 over the past 2 years.
Based on SEC 10-K filings.
$171,568 in FY2016 with a 3-year CAGR of +1.7%.
Declined from $357,532 to $171,568 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +1.7%, indicating consistent growth.
- In FY2016, pp&e (net) increased 0.0% year-over-year.
- Peak pp&e (net) was recorded in FY2014.
- Lowest pp&e (net) in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2016 | $171.6K | +0.0% |
| FY2015 | $171.6K | -52.0% |
| FY2014 | $357.5K | +119.1% |
| FY2013 | $163.1K | +2.0% |
| FY2012 | $160.0K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026